Join the Anesthetic Adjunct group to help and get support from people like you.
Anesthetic Adjunct News
Surgical Outcomes Better With More Women on Your Team
WEDNESDAY, May 15, 2024 – Heading for surgery? The ratio of women to men in the operating room could influence your recovery, new research shows. Hospitals in Canada that had 35% or more surgeons...
AANA Issues Considerations for GLP-1 Receptor Agonist Use Before Surgery
TUESDAY, March 19, 2024 – Considerations for anesthesia care in relation to use of glucagon-like peptide-1 (GLP-1) receptor agonists before surgery are addressed in a report published March 11 by...
Could General Anesthesia in Pregnancy Raise Behavioral Issues in Kids?
MONDAY, March 4, 2024 – Children exposed to anesthesia in the womb when their pregnant mom has surgery are more likely to suffer from behavioral issues later, a new study finds. Exposure to general...
Burnout on the Rise Among Anesthesiologists Since Pandemic
TUESDAY, Nov. 14, 2023 – Burnout has increased among anesthesiologists since the start of the COVID-19 pandemic in 2020, according to a study published in the November issue of Anesthesiology. ...
Use of Manometer Can Reduce Endotracheal Tube Cuff Overinflation
MONDAY, July 24, 2023 – Provider education on use of endotracheal tube (ETT) cuff overinflation can reduce overinflation and related complications, according to a study presented at the annual...
Initiating Patient-Controlled Epidural in OR Beneficial for Pain Control
MONDAY, July 24, 2023 – Initiating patient-controlled epidural anesthesia (PCEA) infusion in the operating room (OR) may improve pain control, according to a study presented at the annual American...
FDA Medwatch Alert: Atracurium Besylate Injection by Sagent Pharmaceuticals: Recall - Potential Impact on Product Sterility
ISSUE: Sagent Pharmaceuticals, Inc. announced the voluntary nationwide recall of two lots of Atracurium Besylate Injection, USP, 50mg/5mL single-dose vials (NDC 25021-659-05) and four lots of...
FDA Medwatch Alert: Vecuronium Bromide For Injection by Sagent Pharmaceuticals, Inc.: Recall - Elevated Impurity Result Detected
ISSUE: Sagent Pharmaceuticals, Inc. announced the voluntary nationwide recall of three lots of Vecuronium Bromide for Injection 10mg (NDC number 25021-657-10) manufactured by Mustafa Nevzat Ilac...
Ask a question
To post your own question to this support group, sign in or create an account.